Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Ongoing Initiated Dec 15, 2025 (10 months ago)

Glycopyrrolate Oral Solution

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Impurities/Degradation Specifications

Cause type: Impurity / degradation

An impurity or degradation product above its limit - other than nitrosamines. Unexpected substances in a batch can make it unsafe or less effective, even when the active ingredient is present. All impurity / degradation recalls.

What was recalled

Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceuticals Inc., Piscataway, NJ 08854, Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854, NDC 72205-070-72

Affected NDC 72205-0070-72

Compare with the code on your package — it is the most precise check available.

Drug: Glycopyrrolate

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Glycopyrrolate
NDC 72205-0070
1 mg/5mL Liquid
Oral
Novadoz Pharmaceuticals LLC Rx
Recalling firm
Novadoz Pharmaceuticals LLC
NDC code
72205-070-72
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0300-2026 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm.

Other Glycopyrrolate recalls

See all
Class II · Moderate risk

Glycopyrrolate

Lack of Assurance of Sterility: Leaking/damaged syringes.

Ongoing Sterility / contamination Denver Solutions, LLC DBA Leiters Health NDC 71449-104-11 D-0370-2025

Other impurity / degradation recalls from 2025

All impurity / degradation recalls
Class III · Low risk

Fesoterodine Fumarate

Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.

Ongoing Impurity / degradation Alembic Pharmaceuticals Limited NDC 62332-176-30 D-0248-2026
Class II · Moderate risk

Ciclopirox Shampoo

Failed Impurity/Degradation specifications: OOS results obtained at the 18-month timepoint

Ongoing Impurity / degradation Sun Pharma /Taro NDC 51672-1351-08 D-0240-2026
Class III · Low risk

Clindamycin Phosphate USP

Failed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay.

Ongoing Impurity / degradation Sun Pharmaceutical Industries INC NDC 51672-4081-4 D-0257-2026